Advertisement
U.S. markets close in 1 hour 58 minutes
Advertisement

Cardinal Health, Inc. (CAH)

NYSE - Nasdaq Real Time Price. Currency in USD
105.72-0.44 (-0.41%)
As of 02:02PM EST. Market open.
  • Dividend

    CAH announced a cash dividend of 0.501 with an ex-date of Dec. 29, 2023

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close106.16
Open105.99
Bid105.65 x 900
Ask105.69 x 800
Day's Range104.93 - 106.10
52 Week Range68.53 - 107.15
Volume710,257
Avg. Volume2,053,506
Market Cap26.057B
Beta (5Y Monthly)0.77
PE Ratio (TTM)173.31
EPS (TTM)0.61
Earnings DateJan 31, 2024 - Feb 05, 2024
Forward Dividend & Yield2.00 (1.89%)
Ex-Dividend DateDec 29, 2023
1y Target Est108.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CAH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cardinal Health, Inc.
    Analyst Report: Cardinal Health, Inc.Cardinal is one of the nation's largest pharmaceutical and medical distribution companies. Its Pharmaceutical segment distributes a wide range of branded and generic drugs, specialty drugs, and over-the-counter products. The Medical segment distributes medical, surgical, and laboratory products to hospitals and other healthcare providers. The company has about 44,000 employees. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more